Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion type Assertion NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_head.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion description "[The observations demonstrate that (1) human ASM tissue expresses messenger RNA and surface protein for FcepsilonRII, as well as for all the Fcgamma receptor subtypes, (2) in contrast to unaltered Fcgamma subtype expression, however, relative to control human ASM, FcepsilonRII is significantly up-regulated in inherently asthmatic ASM tissue, (3) up-regulated expression of FcepsilonRII represents, at least in part, an inducible phenomenon that is largely attributed to IgE immune complex-coupled activation of the receptor, and (4) the latter action is associated with FcepsilonRII-induced autologous elaboration of the proinflammatory cytokine, IL-1beta, by the atopic sensitized ASM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_provenance.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion evidence source_evidence_literature NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_provenance.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion SIO_000772 10482830 NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_provenance.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion wasDerivedFrom befree-20140225 NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_provenance.
- NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_assertion wasGeneratedBy ECO_0000203 NP316775.RAdvlb6sghPL6SlP5ro_k_DNabZhPazFEDILEoKdOWhg4130_provenance.